{"id":"ace-inhibitors-and-diuretics","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Cough"},{"rate":"5-10","effect":"Dizziness"},{"rate":"2-5","effect":"Hyperkalemia (ACE inhibitor component)"},{"rate":"5-15","effect":"Hypokalemia (diuretic component)"},{"rate":"3-8","effect":"Fatigue"},{"rate":"2-5","effect":"Headache"},{"rate":"<1","effect":"Angioedema (rare)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"ACE inhibitors prevent the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby reducing peripheral vascular resistance and blood pressure. Diuretics work through different mechanisms (thiazide, loop, or potassium-sparing) to promote renal sodium and water excretion, decreasing circulating blood volume. The combination provides complementary antihypertensive effects and is commonly used in fixed-dose formulations for improved patient adherence.","oneSentence":"ACE inhibitors block angiotensin-converting enzyme to reduce angiotensin II production and lower blood pressure, while diuretics increase sodium and water excretion to reduce fluid volume and blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:50:51.695Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Heart failure with reduced ejection fraction"},{"name":"Post-myocardial infarction"}]},"trialDetails":[{"nctId":"NCT04040634","phase":"NA","title":"Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Israelita Albert Einstein","startDate":"2019-08-08","conditions":"Diabetes Mellitus, High Blood Pressure, Cardiovascular Diseases","enrollment":9476},{"nctId":"NCT07483151","phase":"","title":"Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-11-01","conditions":"Intraoperative Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","enrollment":110},{"nctId":"NCT02627196","phase":"NA","title":"Baroreflex Activation Therapy for Heart Failure","status":"COMPLETED","sponsor":"CVRx, Inc.","startDate":"2016-04-19","conditions":"Heart Failure","enrollment":1090},{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT07167368","phase":"NA","title":"Exercise Rehabilitation for Cardiorenal Syndrome in HFrEF Patients","status":"RECRUITING","sponsor":"Haiyan Pan","startDate":"2025-09-15","conditions":"Cardiorenal Syndrome","enrollment":60},{"nctId":"NCT05855746","phase":"PHASE3","title":"Colchicine Versus Placebo in Acute Myocarditis Patients","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-07-16","conditions":"Acute Myocarditis","enrollment":300},{"nctId":"NCT01652209","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2013-09-01","conditions":"Acute Myocardial Infarction","enrollment":90},{"nctId":"NCT05780710","phase":"NA","title":"OBPM_Meds2023: Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lowering Medications Intake","status":"RECRUITING","sponsor":"Aktiia SA","startDate":"2023-06-29","conditions":"Hypertension","enrollment":35},{"nctId":"NCT06299514","phase":"NA","title":"RAFT - Pace &Ablate","status":"RECRUITING","sponsor":"Habib Khan","startDate":"2024-04-25","conditions":"Atrial Fibrillation, Heart Failure, Pacemaker","enrollment":600},{"nctId":"NCT07303556","phase":"NA","title":"Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nazarbayev University","startDate":"2024-12-18","conditions":"Heart Failure, Diabete Type 2, Arterial Hypertension","enrollment":120},{"nctId":"NCT07349979","phase":"NA","title":"PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-30","conditions":"Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease","enrollment":654},{"nctId":"NCT07334197","phase":"NA","title":"Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-12-20","conditions":"Ppm, Cardiomyopathy","enrollment":25},{"nctId":"NCT07315139","phase":"NA","title":"Pentoxifylline on Inflammatory Markers in Non-Diabetic Chronic Kidney Disease Patients","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-02-01","conditions":"Pentoxifylline, Inflammatory Markers, Non-Diabetic","enrollment":42},{"nctId":"NCT06023576","phase":"PHASE2","title":"A Study of Blood Pressure Control During Cancer Treatment","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-08-18","conditions":"Breast Cancer, Cardiotoxicity","enrollment":130},{"nctId":"NCT07285187","phase":"","title":"Venous Congestion And Delirium After Cardiac Surgery","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-11-01","conditions":"Intraoperative, Venous Congestion, Postoperative Delirium (POD)","enrollment":120},{"nctId":"NCT05106036","phase":"NA","title":"Preventing Cognitive Decline by Reducing BP Target Trial","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2022-07-11","conditions":"Cognitive Decline, Blood Pressure, Hypertension","enrollment":4000},{"nctId":"NCT07110415","phase":"PHASE4","title":"Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction","status":"RECRUITING","sponsor":"SPH Qingdao Growful Pharmacetical Co.,Ltd","startDate":"2025-11-06","conditions":"Coronary Heart Disease, Cardiac Dysfunction","enrollment":2708},{"nctId":"NCT07232277","phase":"","title":"Venous Congestion and Cardiac Surgery-Associated Acute Kidney Injury","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-10-15","conditions":"Intraoperative, Venous Congestion, Cardiac Surgery-associated Acute Kidney Injury","enrollment":114},{"nctId":"NCT04980716","phase":"PHASE3","title":"Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2021-06-01","conditions":"Non-small Cell Lung Cancer, Cardiovascular Complication","enrollment":524},{"nctId":"NCT05049616","phase":"PHASE4","title":"Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-10-18","conditions":"Hypertension in Pregnancy, Postpartum Preeclampsia","enrollment":70},{"nctId":"NCT06697353","phase":"","title":"An Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in Japan","status":"COMPLETED","sponsor":"Bayer","startDate":"2024-11-01","conditions":"Chronic Heart Failure, Chronic Heart Failure With Reduced Ejection Fraction","enrollment":4936},{"nctId":"NCT07175948","phase":"","title":"Outcome of Clinical Phenotypes of Pediatric Myocarditis at Assiut University Children Hospital","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-06-01","conditions":"Myocarditis, Myocarditis Acute","enrollment":100},{"nctId":"NCT04753840","phase":"NA","title":"Long-term of Remote Ischemic Preconditioning in Patients With Mild Hypertension","status":"RECRUITING","sponsor":"Henan Institute of Cardiovascular Epidemiology","startDate":"2021-07-03","conditions":"Hypertension","enrollment":90},{"nctId":"NCT02472028","phase":"PHASE4","title":"Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-09","conditions":"Cerebrovascular Disorders","enrollment":820},{"nctId":"NCT07124728","phase":"NA","title":"Syntrillo Telehealth Stroke Risk Reduction Study","status":"NOT_YET_RECRUITING","sponsor":"Syntrillo, Inc","startDate":"2025-08","conditions":"Hypertension, Hypertension (HTN), Stroke Prevention","enrollment":68},{"nctId":"NCT05237323","phase":"PHASE3","title":"Micophenolate Mofetil Versus Azathioprine in Myocarditis","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2020-10-01","conditions":"Lymphocytic Myocarditis (Disorder), Heart Failure, Dilated Cardiomyopathy","enrollment":50},{"nctId":"NCT01679132","phase":"NA","title":"BAROSTIM NEO Hypertension Pivotal Trial","status":"SUSPENDED","sponsor":"CVRx, Inc.","startDate":"2013-04-12","conditions":"Uncontrolled Hypertension","enrollment":10},{"nctId":"NCT01471834","phase":"NA","title":"Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"CVRx, Inc.","startDate":"2011-06","conditions":"High Blood Pressure","enrollment":40},{"nctId":"NCT04864145","phase":"NA","title":"Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2021-05-21","conditions":"Aortic Valve Disease","enrollment":210},{"nctId":"NCT04899206","phase":"","title":"ANGIOTENSIN AGENTS AND REDUCTION OF THE PRESCRIPTION OF ANTIDEPRESSANT DRUGS: A RETROSPECTIVE COHORT STUDY USING REAL-WORLD DATA","status":"WITHDRAWN","sponsor":"Sebastian Videla","startDate":"2021-04-12","conditions":"ACE Inhibitors, ARB, Hypertension","enrollment":""},{"nctId":"NCT06964217","phase":"","title":"Immediate Fracture Risk After Antihypertensive Drug Initiation","status":"NOT_YET_RECRUITING","sponsor":"Ajou University School of Medicine","startDate":"2025-06-01","conditions":"Hypertension, Fracture","enrollment":10000000},{"nctId":"NCT05795400","phase":"NA","title":"Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Medical Research Center for Cardiology, Ministry of Health of Russian Federation","startDate":"2022-06-01","conditions":"Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mid Range Ejection Fraction","enrollment":50},{"nctId":"NCT01623492","phase":"","title":"Eisenmenger Quality Enhancement Research Initiative","status":"COMPLETED","sponsor":"Actelion","startDate":"2012-07-01","conditions":"Pulmonary Arterial Hypertension","enrollment":193},{"nctId":"NCT06794710","phase":"NA","title":"Early Identification and Treatment of Rare Cardiomyopathy Cohorts","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2025-02-01","conditions":"Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Metabolic Cardiomyopathy","enrollment":300},{"nctId":"NCT06629246","phase":"NA","title":"Pogejiuxin Decoction Combination of Conventional Western Medicine for the Treatment of Heart Failure with Preserved Ejection Fraction","status":"COMPLETED","sponsor":"Chongqing Traditional Chinese Medicine Hospital","startDate":"2021-09-01","conditions":"Heart Failure, Diastolic (HFpEF)","enrollment":100},{"nctId":"NCT05824923","phase":"PHASE3","title":"A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure","status":"RECRUITING","sponsor":"Pulnovo Medical (Wuxi) Co., Ltd.","startDate":"2023-08-14","conditions":"Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction, Hypertension","enrollment":264},{"nctId":"NCT05419583","phase":"NA","title":"Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2022-11-14","conditions":"Myocardial Infarction Type 2","enrollment":60},{"nctId":"NCT05169411","phase":"","title":"Preserving Kidney Function in Children With Chronic Kidney Disease","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2023-09-22","conditions":"Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 3, Pediatric Kidney Disease","enrollment":20240},{"nctId":"NCT05364190","phase":"PHASE3","title":"Canagliflozin in Patients With Acute Decompansted Heart Failure","status":"COMPLETED","sponsor":"October 6 University","startDate":"2022-06-04","conditions":"Chronic Heart Failure, Acute Heart Failure, Diabetes Mellitus","enrollment":142},{"nctId":"NCT04647292","phase":"PHASE2","title":"European Blood Pressure Intensive Control After Stroke","status":"RECRUITING","sponsor":"University College Dublin","startDate":"2024-05-02","conditions":"Ischemic Stroke, Transient Ischemic Attack","enrollment":142},{"nctId":"NCT01840072","phase":"NA","title":"China Antihypertensive Trial in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Tulane University","startDate":"2009-08","conditions":"Ischemic Stroke","enrollment":4071},{"nctId":"NCT03179163","phase":"PHASE1, PHASE2","title":"Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvessels in Humans","status":"TERMINATED","sponsor":"Penn State University","startDate":"2016-07-20","conditions":"Hypertension,Essential","enrollment":10},{"nctId":"NCT01563731","phase":"PHASE4","title":"Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives","status":"COMPLETED","sponsor":"Istituto Auxologico Italiano","startDate":"2013-04","conditions":"Stroke, Transient Ischemic Attack, Hypertension","enrollment":200},{"nctId":"NCT04030234","phase":"NA","title":"Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study","status":"COMPLETED","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2019-09-17","conditions":"Hypertension","enrollment":11255},{"nctId":"NCT06201000","phase":"","title":"Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients","status":"UNKNOWN","sponsor":"October 6 University","startDate":"2023-12-27","conditions":"Genetic Polymorphisms, Heart Failure","enrollment":282},{"nctId":"NCT06218199","phase":"PHASE4","title":"Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts","status":"RECRUITING","sponsor":"Heart Center Research, LLC","startDate":"2021-07-08","conditions":"Heart Failure, Congestive","enrollment":80},{"nctId":"NCT02351063","phase":"NA","title":"HF Assessment With BNP in the Home: Part II","status":"TERMINATED","sponsor":"Alere San Diego","startDate":"2014-04","conditions":"Heart Failure","enrollment":1},{"nctId":"NCT06176599","phase":"NA","title":"Clinical Study on the Treatment of Diabetic Kidney Disease With Shenxiao Yuning Decoction With Syndrome of Qi and Yin Deficiency and Blood Stasis","status":"UNKNOWN","sponsor":"Lin Liao","startDate":"2022-09-01","conditions":"Diabetic Kidney Disease","enrollment":60},{"nctId":"NCT06175663","phase":"","title":"Hyperintense: Midlife Hypertension and the Brain","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2021-07-06","conditions":"Hypertension, Small Vessel Cerebrovascular Disease","enrollment":130},{"nctId":"NCT06039072","phase":"","title":"Clinical Observation of Long-term Cardiac Function Prognosis in Patients With PPCM Who Have Recovered Cardiac Function","status":"UNKNOWN","sponsor":"Qilu Hospital of Shandong University","startDate":"2023-10-10","conditions":"Cardiomyopathy, Dilated","enrollment":120},{"nctId":"NCT03479554","phase":"PHASE3","title":"China Antihypertensive Trial in Acute Ischemic Stroke II","status":"COMPLETED","sponsor":"Tulane University","startDate":"2018-06-13","conditions":"Acute Ischemic Stroke","enrollment":4810},{"nctId":"NCT02592499","phase":"NA","title":"Swedish Evaluation of Left Ventricular Assist Device as Permanent Treatment in End-stage Heart Failure","status":"UNKNOWN","sponsor":"Vastra Gotaland Region","startDate":"2016-06","conditions":"End-stage Heart Failure","enrollment":80},{"nctId":"NCT05087940","phase":"","title":"Treatment of Resistant Hypertension: Cohort Study","status":"COMPLETED","sponsor":"Galenika AD Beograd","startDate":"2021-06-01","conditions":"Resistant Hypertension","enrollment":731},{"nctId":"NCT05636631","phase":"","title":"Chest U/S in Differentiating Lung Congestion & Pneumonia in Adult Critically-ill Patients and Its Prognostic Impact","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-11-01","conditions":"Pneumonia, Pulmonary Edema","enrollment":60},{"nctId":"NCT05633758","phase":"PHASE2","title":"Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure","status":"WITHDRAWN","sponsor":"Scripps Health","startDate":"2014-03","conditions":"Acute Decompensated Heart Failure","enrollment":""},{"nctId":"NCT03461003","phase":"PHASE4","title":"N-of-1 Trials In Children With Hypertension","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-04-02","conditions":"Pediatric Hypertension","enrollment":49},{"nctId":"NCT05470764","phase":"PHASE1","title":"Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers","status":"COMPLETED","sponsor":"Darnitsa Pharmaceutical Company","startDate":"2021-05-30","conditions":"Bioequivalence, Healthy Subjects","enrollment":52},{"nctId":"NCT05464745","phase":"PHASE1","title":"Bioequivalence Study of 8 mg Perindopril Tert-butylamine / 2.5 mg Indapamide Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide Film-coated Tablets in Healthy Volunteers","status":"COMPLETED","sponsor":"Darnitsa Pharmaceutical Company","startDate":"2021-05-19","conditions":"Bioequivalence, Healthy Subjects","enrollment":42},{"nctId":"NCT05352633","phase":"NA","title":"Effects of Intensive Systolic Blood Pressure Lowering Treatment on Out-of-office Blood Pressure - an Ancillary Study to Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study","status":"UNKNOWN","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2022-07-18","conditions":"Blood Pressure","enrollment":710},{"nctId":"NCT05045274","phase":"NA","title":"The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-12","conditions":"STEMI - ST Elevation Myocardial Infarction, Left Ventricular Systolic Dysfunction","enrollment":300},{"nctId":"NCT02774460","phase":"PHASE4","title":"The Precision Hypertension Care Study","status":"COMPLETED","sponsor":"Uppsala University","startDate":"2017-02-20","conditions":"Hypertension","enrollment":280},{"nctId":"NCT03430284","phase":"PHASE4","title":"Multifactorial Intervention on Diabetes (MIDiab Study)","status":"UNKNOWN","sponsor":"Shandong Provincial Hospital","startDate":"2018-04-01","conditions":"Diabetes Mellitus, Type 2","enrollment":6300},{"nctId":"NCT03722524","phase":"","title":"The Use of TrIple Fixed-dose Combination in the Treatment of Arterial Hypertension","status":"COMPLETED","sponsor":"Servier Russia","startDate":"2018-10-01","conditions":"Arterial Hypertension","enrollment":1247},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT03587103","phase":"NA","title":"Learning Implementation of Guideline-based Decision Support System for Hypertension Treatment: Testing Alternative Antihypertensive Regimens Using ACE-Inhibitors, Calcium Channel Blockers and Diuretics (LIGHT-ACD)","status":"UNKNOWN","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2019-08-21","conditions":"Hypertension","enrollment":5000},{"nctId":"NCT00679237","phase":"NA","title":"Risk Reduction in Coronary Heart Disease","status":"COMPLETED","sponsor":"Sorlandet Hospital HF","startDate":"2007-09","conditions":"Coronary Heart Disease","enrollment":1600},{"nctId":"NCT04162444","phase":"","title":"Results of the Aortic Valve Reconstruction in Children","status":"RECRUITING","sponsor":"National Medical Research Center for Children's Health, Russian Federation","startDate":"2020-02-18","conditions":"Aortic Valve Insufficiency","enrollment":40},{"nctId":"NCT01206062","phase":"NA","title":"Systolic Blood Pressure Intervention Trial","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2010-10","conditions":"Hypertension","enrollment":9361},{"nctId":"NCT04330300","phase":"PHASE4","title":"Coronavirus (COVID-19) ACEi/ARB Investigation","status":"SUSPENDED","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2020-04-30","conditions":"Hypertension, COVID-19","enrollment":2414},{"nctId":"NCT04364113","phase":"PHASE3","title":"The Modification of Diet in Renal Disease Study","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"1989-01-01","conditions":"Chronic Renal Disease","enrollment":840},{"nctId":"NCT04317339","phase":"PHASE2","title":"The Efficacy and Safety of Zhigancao Tang Granule for HFpEF of Qi-Yin Dificiency","status":"UNKNOWN","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2020-03-20","conditions":"Heart Failure With Preserved Ejection Fraction","enrollment":122},{"nctId":"NCT03150888","phase":"","title":"Multi-provincial Cohort for Hypertension (MUCH)","status":"UNKNOWN","sponsor":"Beijing Institute of Heart, Lung and Blood Vessel Diseases","startDate":"2017-07-03","conditions":"Hypertension","enrollment":30000},{"nctId":"NCT04185857","phase":"","title":"MRA and ARB Treatment in Screening of Primary Aldosteronism","status":"COMPLETED","sponsor":"University Hospital Padova","startDate":"2018-01-01","conditions":"Primary Aldosteronism Due to Aldosterone Producing Adenoma","enrollment":50},{"nctId":"NCT01471860","phase":"NA","title":"BAROSTIM NEO System in the Treatment of Heart Failure","status":"UNKNOWN","sponsor":"CVRx, Inc.","startDate":"2011-08","conditions":"Heart Failure","enrollment":94},{"nctId":"NCT02007720","phase":"PHASE3","title":"Efficacy, Safety and Tolerability of Sexelaxin When Added to Standard Therapy in AHF","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2014-03-12","conditions":"Acute Heart Failure","enrollment":876},{"nctId":"NCT02220335","phase":"NA","title":"Pulmonary Arterial Denervation in Patients With Pulmonary Hypertension Associated With the Left Heart Failure","status":"COMPLETED","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2014-08-08","conditions":"Pulmonary Hypertension","enrollment":98},{"nctId":"NCT01720160","phase":"NA","title":"BAROSTIM® Hope for Heart Failure Study","status":"UNKNOWN","sponsor":"CVRx, Inc.","startDate":"2012-11","conditions":"Heart Failure","enrollment":98},{"nctId":"NCT03921736","phase":"PHASE4","title":"Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.","status":"COMPLETED","sponsor":"Anna Posadzy-Małaczyńska","startDate":"2000-01-10","conditions":"Hypertension, Hyperuricemia, Menopause","enrollment":180},{"nctId":"NCT02832973","phase":"PHASE4","title":"Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension","status":"COMPLETED","sponsor":"Sao Jose do Rio Preto Medical School","startDate":"2015-09","conditions":"Hypertension Resistant to Conventional Therapy","enrollment":72},{"nctId":"NCT02064868","phase":"PHASE3","title":"Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2014-01-31","conditions":"Acute Heart Failure (AHF)","enrollment":2666},{"nctId":"NCT03195023","phase":"PHASE4","title":"Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)","status":"UNKNOWN","sponsor":"Hospital General Universitario Gregorio Marañon","startDate":"2015-06","conditions":"Renal Insufficiency, Chronic, Proteinuria","enrollment":106},{"nctId":"NCT02620384","phase":"PHASE3","title":"Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.","status":"TERMINATED","sponsor":"Aultman Health Foundation","startDate":"2015-10-01","conditions":"Acute Decompensated Heart Failure","enrollment":147},{"nctId":"NCT03747978","phase":"PHASE4","title":"Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes","status":"COMPLETED","sponsor":"Yaounde Central Hospital","startDate":"2016-10-01","conditions":"Diabetes Mellitus, Type 2, Hypertension","enrollment":30},{"nctId":"NCT02412761","phase":"NA","title":"Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2013-06","conditions":"Essential Hypertension","enrollment":42},{"nctId":"NCT02814552","phase":"NA","title":"OPTImizing Precision of Hypertension Care to Maximize Blood Pressure Control Pilot (OPTI-BP Pilot)","status":"COMPLETED","sponsor":"University of Florida","startDate":"2016-06-18","conditions":"High Blood Pressure","enrollment":47},{"nctId":"NCT03600220","phase":"NA","title":"Exploring the Effect of Combined Chinese and Western Treatment on Home Medical Care","status":"UNKNOWN","sponsor":"Taipei City Hospital","startDate":"2018-06-01","conditions":"Hypertension","enrollment":80},{"nctId":"NCT01996085","phase":"NA","title":"Non-invasive Haemodynamic Assessment in Hypertension","status":"COMPLETED","sponsor":"Military Institute od Medicine National Research Institute","startDate":"2013-01","conditions":"Arterial Hypertension","enrollment":144},{"nctId":"NCT01953874","phase":"NA","title":"Cardiovascular Improvements With MV ASV Therapy in Heart Failure","status":"TERMINATED","sponsor":"ResMed","startDate":"2013-12","conditions":"Acute Decompensated Heart Failure, Sleep Disordered Breathing","enrollment":126},{"nctId":"NCT01685840","phase":"NA","title":"Guiding Evidence Based Therapy Using Biomarker Intensified Treatment","status":"TERMINATED","sponsor":"Duke University","startDate":"2012-12","conditions":"Heart Failure","enrollment":894},{"nctId":"NCT02859311","phase":"PHASE4","title":"A Pilot Feasibility Study in Recovered Heart Failure","status":"UNKNOWN","sponsor":"Royal Brompton & Harefield NHS Foundation Trust","startDate":"2016-04","conditions":"Heart Failure","enrollment":50},{"nctId":"NCT02967484","phase":"NA","title":"Acupuncture Lowering Blood Pressure for Secondary Prevention of Stroke","status":"UNKNOWN","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2016-11-20","conditions":"Cerebral Infarction","enrollment":480},{"nctId":"NCT01891513","phase":"","title":"ACE Inhibitors Combined With Exercise for Seniors - Pilot Study","status":"COMPLETED","sponsor":"University of Florida","startDate":"2014-01","conditions":"Hypertension, Aging","enrollment":104},{"nctId":"NCT01167920","phase":"NA","title":"Virtual Hypertension Clinic","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2009-11","conditions":"Hypertension","enrollment":74},{"nctId":"NCT01904695","phase":"EARLY_PHASE1","title":"Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study","status":"COMPLETED","sponsor":"China Academy of Chinese Medical Sciences","startDate":"2013-08","conditions":"Primary Hypertension, Hypertension, Resistant to Conventional Therapy","enrollment":192},{"nctId":"NCT02008110","phase":"PHASE4","title":"Carbohydrate Antigen 125-guided Therapy in Heart Failure","status":"COMPLETED","sponsor":"Fundación para la Investigación del Hospital Clínico de Valencia","startDate":"2011-12","conditions":"Heart Failure","enrollment":360},{"nctId":"NCT02646397","phase":"PHASE4","title":"Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension","status":"UNKNOWN","sponsor":"Shanghai Changzheng Hospital","startDate":"2016-02","conditions":"Chronic Kidney Disease","enrollment":508},{"nctId":"NCT00524862","phase":"NA","title":"Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death","status":"TERMINATED","sponsor":"Unity Health Toronto","startDate":"2007-10","conditions":"Coronary Heart Disease, Congestive Heart Failure, Ventricular Dysfunction","enrollment":5000},{"nctId":"NCT01202006","phase":"NA","title":"Strategy to Recognize and Initiate Treatment of Chronic Heart Failure","status":"COMPLETED","sponsor":"UMC Utrecht","startDate":"2010-10","conditions":"Heart Failure","enrollment":585},{"nctId":"NCT01258764","phase":"NA","title":"Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril","status":"COMPLETED","sponsor":"Scripps Translational Science Institute","startDate":"2010-11","conditions":"Hypertension, Grade 1, Hypertension Treatment, N of 1 Study Design","enrollment":2},{"nctId":"NCT02244177","phase":"","title":"Relationship of Essential Hypertension and Its Treatments on the Postoperative Pain Management: a Prospective, Observational, Cross-sectional Study","status":"UNKNOWN","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2013-11","conditions":"Hypertension","enrollment":300}],"_emaApprovals":[],"_faersSignals":[{"count":8,"reaction":"RENAL FAILURE"},{"count":4,"reaction":"VOMITING"},{"count":3,"reaction":"ARTHRALGIA"},{"count":3,"reaction":"BACK PAIN"},{"count":3,"reaction":"FLANK PAIN"},{"count":3,"reaction":"HYPERTENSION"},{"count":3,"reaction":"NAUSEA"},{"count":3,"reaction":"RENAL FAILURE ACUTE"},{"count":3,"reaction":"URINE OUTPUT DECREASED"},{"count":2,"reaction":"BLOOD CREATININE INCREASED"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"ACE Inhibitors and Diuretics","genericName":"ACE Inhibitors and Diuretics","companyName":"The University of Texas Health Science Center, Houston","companyId":"the-university-of-texas-health-science-center-houston","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ACE inhibitors block angiotensin-converting enzyme to reduce angiotensin II production and lower blood pressure, while diuretics increase sodium and water excretion to reduce blood volume and fluid overload. Used for Hypertension, Heart failure with reduced ejection fraction, Post-myocardial infarction.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}